Although the identification of conolidine as a possible novel analgesic agent provides an additional avenue to address the opioid disaster and manage CNCP, further more experiments are required to be familiar with its mechanism of action and utility and efficacy in taking care of CNCP.Conolidine isn’t simply a passing craze in soreness aid—it�